Nursing home bed prices approach $100K even with sluggish occupancy
By
Joe Bush
Nov 02, 2022
Nursing care bed prices have risen 21% from their pre-pandemic levels, despite a glacially paced occupancy recovery and ongoing stigma against the sector, a noted long-term care analyst reported Tuesday.
NIA funds $3.7M study of dementia and diabetes in U.S. Latinos
By
Alicia Lasek
Nov 01, 2022
A new study will examine how diabetes affects brain changes over time in adults with Hispanic ancestry.
Clinical briefs for Friday, Oct. 21
By
Alicia Lasek
Oct 21, 2022
Use peer mentoring, not a ‘diet of distraction’ to combat isolation in long-term care … Behavioral health drug prescriptions surged during pandemic, Medicare data show … Diabetes drugs linked to...
Also in the News for Thursday, Oct. 13, 2022
By
Joe Bush
Oct 13, 2022
NIC names new CEO … Stressed Oklahoma nursing homes closing doors … Arkansas business sends supplies to storm-stricken Florida nursing homes
NIH: COVID rebound after Paxlovid may signal a strong immune response
By
Alicia Lasek
Oct 11, 2022
Patients who had rebound symptoms after taking Paxlovid showed a more robust immune response to SARS-CoV-2 than patients with no rebound, investigators reported.
Pharmacists fill care gaps as COVID strategies develop
By
John Hall
Oct 06, 2022
The year 2022 has been a challenging and, at times, breakthrough year for drugs in long-term care. Unfortunately, many of the people who managed and dispensed them in nursing homes were absent. “Staffing...
Among the risks: upticks in instances of workplace violence and ransomware attacks, as well as ongoing fall risks from a notable increase in the use of antipsychotics.
Providers urged to remember COVID-19 tactics as dangerous flu season looms
By
Joe Bush
Oct 06, 2022
Influenza, once the respiratory scourge that nursing home residents and professionals feared the most each year before COVID-19 hit, should be back on providers’ radar in a big way, experts warn.
CDC: Two booster shots cut severe COVID risk in nursing home residents by 74 percent
By
Alicia Lasek
Oct 03, 2022
Nursing home residents who received a second mRNA booster shot during omicron were much less likely to suffer severe COVID-19 outcomes than their peers who received only one dose, a new study shows.
New Alzheimer’s drug shows promise in slowing disease
By
John Roszkowski
Sep 29, 2022
In a potentially significant breakthrough in the treatment of Alzheimer’s disease, recently completed clinical trials show a new experimental drug treatment could significantly slow the progression of...